Abdulrafeh Naqash to Prognosis
This is a "connection" page, showing publications Abdulrafeh Naqash has written about Prognosis.
Connection Strength
0.302
-
Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort. Cancer Immunol Immunother. 2020 Jul; 69(7):1177-1187.
Score: 0.145
-
Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial. Cancer. 2022 08 15; 128(16):3067-3079.
Score: 0.043
-
Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer. Mol Cancer Ther. 2021 12; 20(12):2577-2584.
Score: 0.040
-
Advances in the management of alveolar soft part sarcoma. Curr Probl Cancer. 2021 08; 45(4):100775.
Score: 0.040
-
Emerging Role of Immune Checkpoint Blockade in Pancreatic Cancer. Int J Mol Sci. 2018 Nov 07; 19(11).
Score: 0.033